Campbells Co (CPB) concluded trading on Wednesday at a closing price of $38.50, with 3.96 million shares of worth about $152.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -25.33% during that period and on Wednesday the price saw a loss of about -0.77%. Currently the company’s common shares owned by public are about 298.00M shares, out of which, 196.42M shares are available for trading.
Stock saw a price change of -0.21% in past 5 days and over the past one month there was a price change of 0.89%. Year-to-date (YTD), CPB shares are showing a performance of -8.07% which decreased to -9.86% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $36.92 but also hit the highest price of $52.81 during that period. The average intraday trading volume for Campbells Co shares is 3.22 million. The stock is currently trading -3.64% below its 20-day simple moving average (SMA20), while that difference is down -1.66% for SMA50 and it goes to -13.79% lower than SMA200.
Campbells Co (NASDAQ: CPB) currently have 298.00M outstanding shares and institutions hold larger chunk of about 58.13% of that.
The stock has a current market capitalization of $11.48B and its 3Y-monthly beta is at 0.20. PE ratio of stock for trailing 12 months is 22.18, while it has posted earnings per share of $1.74 in the same period. Its PEG reads 8.77 and has Quick Ratio of 0.55 while making debt-to-equity ratio of 2.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CPB, volatility over the week remained 2.20% while standing at 3.52% over the month.
Stock’s fiscal year EPS is expected to drop by -2.52% while it is estimated to increase by 3.45% in next year. EPS is likely to shrink at an annualized rate of 2.53% for next 5-years, compared to annual growth of 15.98% made by the stock over the past 5-years.
Coverage by JP Morgan stated Campbells Co (CPB) stock as a Neutral in their note to investors on March 06, 2025, suggesting a price target of $37 for the stock. On November 14, 2024, Piper Sandler Upgrade their recommendations, while on October 07, 2024, Bernstein Upgrade their ratings for the stock with a price target of $58. Stock get a Neutral rating from DA Davidson on September 27, 2024.
